Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
Werte in diesem Artikel
The latest trading session saw Oscar Health, Inc. (OSCR) ending at $14.17, denoting a -0.07% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.16% for the day. At the same time, the Dow added 0.86%, and the tech-heavy Nasdaq lost 0.38%.Prior to today's trading, shares of the company had gained 3.81% over the past month. This has outpaced the Finance sector's loss of 5.04% and the S&P 500's loss of 2.2% in that time.The investment community will be closely monitoring the performance of Oscar Health, Inc. in its forthcoming earnings report. The company is scheduled to release its earnings on February 4, 2025. The company is expected to report EPS of -$0.58, up 12.12% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $2.46 billion, indicating a 71.91% growth compared to the corresponding quarter of the prior year.Any recent changes to analyst estimates for Oscar Health, Inc. should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Oscar Health, Inc. possesses a Zacks Rank of #2 (Buy).Looking at its valuation, Oscar Health, Inc. is holding a Forward P/E ratio of 18.54. This valuation marks a premium compared to its industry's average Forward P/E of 9.46.It is also worth noting that OSCR currently has a PEG ratio of 0.57. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. Insurance - Multi line stocks are, on average, holding a PEG ratio of 0.84 based on yesterday's closing prices.The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 56, finds itself in the top 23% echelons of all 250+ industries.The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.1% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oscar Health, Inc. (OSCR): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Oscar Health A
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Oscar Health A
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Oscar Health Inc Registered Shs -A-
Analysen zu Oscar Health Inc Registered Shs -A-
Keine Analysen gefunden.